Other Chinese pharmaceutical companies such as Innovent Biologics, Hengrui Medicine

The requested name does not identify a single company. Instead, it refers to a plural grouping: other Chinese pharmaceutical companies such as Innovent Biologics and Hengrui Medicine. Both are active, public Chinese biopharma/pharma companies with commercial products, global clinical pipelines, and significant in-house R&D and manufacturing capabilities. Innovent is best known for its antibody-centered biopharma platform and has expanded into oncology, cardiometabolic, autoimmune, and ophthalmology assets, while Hengrui is a broader innovative pharmaceutical company spanning oncology, immunology, metabolic disease, cardiovascular disease, neuroscience, and additional therapeutic areas. Because the input is not an exact single-entity company name, the record below consolidates representative information for the two explicitly named companies and marks is_match as false.